Abstract
Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have